Izotropic Corporation's IzoView Breast CT Imaging System Offers Advanced Breast Cancer Detection

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) has unveiled an educational overview of its IzoView Breast CT Imaging System, highlighting its advantages over existing breast imaging technologies. The IzoView system provides true 3D, ultra-high-resolution imaging without the need for breast compression, positioning itself as a significant advancement in the field. Developed under a global license from UC Davis, the technology is designed to fill the gap between digital breast tomosynthesis and MRI, offering 100x greater spatial resolution than MRI at a reduced cost and with quicker scan times.

This innovation is particularly beneficial for women with dense breast tissue, a group that often faces challenges with traditional imaging methods. The IzoView system's ability to deliver detailed images without compression could revolutionize breast cancer screening, diagnosis, and treatment planning. For more details on the IzoView Breast CT Imaging System, visit https://ibn.fm/NbLB2.